Strides Pharma Science Ltd Reports FY 2024-25 Financial Results with 95.22% Export Contribution

Strides Pharma Science Limited, a prominent player in the pharmaceutical industry, has released its Business Responsibility & Sustainability Report (BRSR) for the financial year ended March 31, 2025. The company reported a standalone total turnover of INR 21,856.11 million, with a significant 95.22% contribution from exports. Strides' operations span across multiple locations in India and abroad, with a strong focus on manufacturing chemical and chemical products, pharmaceuticals, medicinal chemical, and botanical products. The company serves a diverse range of customers, including wholesalers, large pharmacy chains, global donor-funded institutions, and large pharmaceutical companies. As of the end of FY 2024-25, Strides employed a total of 2,560 permanent employees and 2,616 workers, with a notable 25% representation of women in key management positions.